HARVARD BIOSCIENCE, INC. (HBIO) Free cash flow 2017–2025
HARVARD BIOSCIENCE, INC. (HBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$5.5MFY2025 · since FY2017: $167,000 → $5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.5M | +554.4% |
| FY2024 | -$1.2M | -109.8% |
| FY2023 | $12.2M | +2894.5% |
| FY2022 | -$438,000 | -753.7% |
| FY2021 | $67,000 | -99.2% |
| FY2020 | $8.2M | +19.8% |
| FY2019 | $6.8M | +259.8% |
| FY2018 | $1.9M | +1036.5% |
| FY2017 | $167,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice